<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02382328</url>
  </required_header>
  <id_info>
    <org_study_id>265/14</org_study_id>
    <nct_id>NCT02382328</nct_id>
  </id_info>
  <brief_title>Alpha Lipoic Acid on Clinical and Electrophysiological Recovery in Carpal Tunnel Syndrome Undergoing Surgical Release</brief_title>
  <official_title>Effectiveness of Alpha Lipoic Acid on Clinical and Electrophysiological Recovery in Patients With Carpal Tunnel Syndrome Surgical Release</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Civil de Guadalajara</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Civil de Guadalajara</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this study is to determine the effectiveness of use Alpha lipoic acid
      before and after surgical release of carpal tunnel syndrome. Controlled Clinical trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main purpose of this study is to determine the effectiveness of using an oral
      supplementation of alpha lipoid acid to improve clinical and electrophysiological recovery
      after carpal tunnel release surgery. This research is designed as a double blinded clinical
      trial, with a calculated sample size of 40 patients, divided in two groups of 20 (A placebo,
      B alpha lipoid acid). All patients will undergo open carpal tunnel release surgery, the
      procedure will be performed by an expert surgeon. A total of four visits will be performed as
      follows: T0. baseline 4 weeks before surgery, T1 immediately before surgery, T2: 4 weeks
      after surgery, T3: 8 weeks after surgery, T4: 12 weeks after surgery. The assessment to be
      perform on each visit includes: physical examination, Boston Questionary for Carpal Tunnel
      Syndrome. Nerve conduction study and ecographic evaluation will be performed on visits T0, T1
      and T4. Statistical Analysis: Categorical variables will be assessed as counts and percent
      frequency and compared using the chi-squared test. All statistical analyses will be performed
      using the SPSS 21.0 package (SPSS Inc., Chicago, IL, USA). A two-tailed P value &lt; 0.05 was
      considered statistically significant.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>median nerve sensory latency (using nerve conduction studies to determine median sensory latency.)</measure>
    <time_frame>120 days after surgery</time_frame>
    <description>using nerve conduction studies to determine median sensory latency.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>cross sectional area of median nerve (sonographic measurement to determine cross sectional area of median nerve.)</measure>
    <time_frame>120 days after surgery</time_frame>
    <description>sonographic measurement to determine cross sectional area of median nerve.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Carpal Tunnel Syndrome</condition>
  <arm_group>
    <arm_group_label>alpha lipoic acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>600mg/24 oral pills alpha lipoic acid 28 days before and 120 days after carpal tunnel release.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Oral pills of mangensium inactivated 28 days before and 120 days after carpal tunnel release.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>alpha lipoic acid</intervention_name>
    <description>comparison of 600mg/24h oral, alpha lipoid acid, 28 days before and 120 days after surgery (carpal tunnel release) versus placebo in carpal tunnel syndrome patients.</description>
    <arm_group_label>alpha lipoic acid</arm_group_label>
    <other_name>thiocitic acid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo oral pills, 28 days before and 120 days after surgery (carpal tunnel release) versus placebo in carpal tunnel syndrome patients.</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>inactive magnesium</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinical and electrophysiological diagnosis of carpal tunnel syndrome

        Exclusion Criteria:

          -  rheumatic diseases

          -  distal radio or carpal fractures.

          -  pregnant women

          -  alpha lipoid acid allergy

          -  local injections (ej. steroid carpal injections)

          -  peripheral nervous system diseases (which may cause nerve conduction study
             abnormalities).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leonel Garcia, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Guadalajara</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Antiguo Hospital Civil de Guadalajara Fray Antonio Alcalde</name>
      <address>
        <city>Guadalajara</city>
        <state>Jalisco</state>
        <zip>44280</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <results_reference>
    <citation>Pajardi G, Bortot P, Ponti V, Novelli C. Clinical usefulness of oral supplementation with alpha-lipoic Acid, curcumin phytosome, and B-group vitamins in patients with carpal tunnel syndrome undergoing surgical treatment. Evid Based Complement Alternat Med. 2014;2014:891310. doi: 10.1155/2014/891310. Epub 2014 Jan 19.</citation>
    <PMID>24563654</PMID>
  </results_reference>
  <results_reference>
    <citation>Di Geronimo G, Caccese AF, Caruso L, Soldati A, Passaretti U. Treatment of carpal tunnel syndrome with alpha-lipoic acid. Eur Rev Med Pharmacol Sci. 2009 Mar-Apr;13(2):133-9.</citation>
    <PMID>19499849</PMID>
  </results_reference>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 18, 2015</study_first_submitted>
  <study_first_submitted_qc>March 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 6, 2015</study_first_posted>
  <last_update_submitted>August 8, 2016</last_update_submitted>
  <last_update_submitted_qc>August 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Civil de Guadalajara</investigator_affiliation>
    <investigator_full_name>Elisa Alejandra Monroy Guizar</investigator_full_name>
    <investigator_title>Medico Especialista Medicina de Rehabilitaci√≥n</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Carpal Tunnel Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thioctic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

